Skip to main content
CDC Website

Physicians

Physicians

Long-Acting HIV Antiretroviral Therapy (ART): Cabotegravir/Rilpivirine (CAB/RPV)

This guideline provides recommendations for HIV care teams on implementing long-acting injectable HIV treatment, including cabotegravir and rilpivirine. 

Backsplicing of the HIV-1 Transcript Generates Multiple CircRNAs to Promote Viral Replication

This journal examines the role of circular RNAs (circRNAs) in HIV-1 replication, highlighting the discovery that backsplicing of the HIV-1 transcript produces multiple circRNAs that enhance viral replication. 

Outcomes of a Pilot Randomized Clinical Trial Testing Brief Interventions to Increase HIV Pre-Exposure Prophylaxis Uptake Among Rural People Who Inject Drugs Attending Syringe Services Programs

This journal presents findings from a pilot randomized clinical trial evaluating two brief interventions aimed at increasing HIV pre-exposure prophylaxis (PrEP) uptake among rural people who inject drugs (PWID) attending syringe services programs (SSPs) in Kentucky. 

TB Treatment Regimen Cheat Sheet

This fact sheet provides a detailed comparison of tuberculosis (TB) treatment regimens, encompassing both drug-sensitive and drug-resistant TB. 

Integrating Management of Hepatitis C Infection into Primary Care: The Key to Hepatitis C Elimination Efforts

This journal discusses the integration of hepatitis C management into primary care as a key strategy for eliminating the disease. It examines barriers to care, the role of direct-acting antivirals, and the importance of screening and treatment within primary care settings.

Clinical Course of Autoimmune Hepatitis in Hispanic and African American Patients: A Retrospective Study at a South Bronx Hospital

This journal examines the clinical course of autoimmune hepatitis (AIH) in Hispanic and African American patients at a South Bronx hospital. The findings contribute to a better understanding of AIH in diverse racial and ethnic groups, emphasizing the need for tailored healthcare strategies.

Heplisav-B vs Standard Hepatitis B Vaccine Booster for Health Care Workers

This journal compares the effectiveness of Heplisav-B and standard hepatitis B vaccines as boosters for healthcare workers with low immunity to hepatitis B, measured by anti-HBs antibody levels. Results show that Heplisav-B offers a significantly higher seropositivity rate (99.4%) compared to the standard vaccine (92.7%).

Best Practices for Engaging with Affected Communities: Chronic Hepatitis B as a Case Study

This journal outlines best practices for engaging communities affected by chronic hepatitis B, emphasizing the importance of involving individuals with lived experiences in public health initiatives to improve diagnosis and treatment outcomes.

Peer-Assisted Telemedicine Hepatitis-C Treatment for People Who Use Drugs in Rural Communities: A Mixed Methods Study

This journal evaluates the Oregon HOPE TeleHCV study, a peer-facilitated telemedicine model (Peer TeleHCV) for hepatitis C virus (HCV) treatment among people who use drugs (PWUD) in rural Oregon. The findings highlight high patient satisfaction and key factors that enhanced implementation, demonstrating the model’s potential to reduce barriers and improve treatment access.

What Are the Risks of Untreated Hep C?

This webpage explores the risks of untreated hepatitis C, highlighting its potential to cause severe liver damage, cirrhosis, liver failure, and even liver cancer. Beyond liver-related issues, the virus can also contribute to complications such as fatigue, joint pain, kidney disease, and diabetes. Early diagnosis and treatment are essential to preventing these long-term health risks and improving overall well-being.